0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Maternal and Infant Probiotics Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-19T18921
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Maternal and Infant Probiotics Market Research Report 2025
BUY CHAPTERS

Global Maternal and Infant Probiotics Market Research Report 2025

Code: QYRE-Auto-19T18921
Report
January 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Maternal and Infant Probiotics Market Size

The global market for Maternal and Infant Probiotics was valued at US$ 6117 million in the year 2024 and is projected to reach a revised size of US$ 10970 million by 2031, growing at a CAGR of 8.7% during the forecast period.

Maternal and Infant Probiotics Market

Maternal and Infant Probiotics Market

Maternal and infant probiotics refer to probiotic supplements designed for mothers, infants and young children. These products contain active microorganisms that are beneficial to maternal and infant health, aiming to promote digestive health, enhance immunity, and prevent or reduce allergic symptoms by regulating the balance of intestinal flora. Maternal and infant probiotic products are often specially formulated to ensure safety and suitability for use by the mother during pregnancy and lactation, and for the infant and young child during their early development.
North American market for Maternal and Infant Probiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Maternal and Infant Probiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Maternal and Infant Probiotics include Bayer Corporation, Nestle S.A, Mommy’s Bliss Inc, LoveBug Probiotics, BioGaia AB, MaryRuth Organics, Infinant Health, Biomeology, Nordic Naturals, Culturelle, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Maternal and Infant Probiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Maternal and Infant Probiotics.
The Maternal and Infant Probiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Maternal and Infant Probiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Maternal and Infant Probiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Maternal and Infant Probiotics Market Report

Report Metric Details
Report Name Maternal and Infant Probiotics Market
Accounted market size in year US$ 6117 million
Forecasted market size in 2031 US$ 10970 million
CAGR 8.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Powder
  • Liquid
  • Soft Candy
Segment by Application
  • Hospital
  • Clinic
  • Supermarkets
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer Corporation, Nestle S.A, Mommy’s Bliss Inc, LoveBug Probiotics, BioGaia AB, MaryRuth Organics, Infinant Health, Biomeology, Nordic Naturals, Culturelle, Life-Space, Witsbb, Biostime, BY-health
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Maternal and Infant Probiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Maternal and Infant Probiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Maternal and Infant Probiotics Market growing?

Ans: The Maternal and Infant Probiotics Market witnessing a CAGR of 8.7% during the forecast period 2025-2031.

What is the Maternal and Infant Probiotics Market size in 2031?

Ans: The Maternal and Infant Probiotics Market size in 2031 will be US$ 10970 million.

Who are the main players in the Maternal and Infant Probiotics Market report?

Ans: The main players in the Maternal and Infant Probiotics Market are Bayer Corporation, Nestle S.A, Mommy’s Bliss Inc, LoveBug Probiotics, BioGaia AB, MaryRuth Organics, Infinant Health, Biomeology, Nordic Naturals, Culturelle, Life-Space, Witsbb, Biostime, BY-health

What are the Application segmentation covered in the Maternal and Infant Probiotics Market report?

Ans: The Applications covered in the Maternal and Infant Probiotics Market report are Hospital, Clinic, Supermarkets, Others

What are the Type segmentation covered in the Maternal and Infant Probiotics Market report?

Ans: The Types covered in the Maternal and Infant Probiotics Market report are Powder, Liquid, Soft Candy

Recommended Reports

Maternal & Infant Nutrition

Probiotic Supplement Markets

Infant Probiotics & Care

1 Maternal and Infant Probiotics Market Overview
1.1 Product Definition
1.2 Maternal and Infant Probiotics by Type
1.2.1 Global Maternal and Infant Probiotics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Liquid
1.2.4 Soft Candy
1.3 Maternal and Infant Probiotics by Application
1.3.1 Global Maternal and Infant Probiotics Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Supermarkets
1.3.5 Others
1.4 Global Maternal and Infant Probiotics Market Size Estimates and Forecasts
1.4.1 Global Maternal and Infant Probiotics Revenue 2020-2031
1.4.2 Global Maternal and Infant Probiotics Sales 2020-2031
1.4.3 Global Maternal and Infant Probiotics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Maternal and Infant Probiotics Market Competition by Manufacturers
2.1 Global Maternal and Infant Probiotics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Maternal and Infant Probiotics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Maternal and Infant Probiotics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Maternal and Infant Probiotics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Maternal and Infant Probiotics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Maternal and Infant Probiotics, Product Type & Application
2.7 Global Key Manufacturers of Maternal and Infant Probiotics, Date of Enter into This Industry
2.8 Global Maternal and Infant Probiotics Market Competitive Situation and Trends
2.8.1 Global Maternal and Infant Probiotics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Maternal and Infant Probiotics Players Market Share by Revenue
2.8.3 Global Maternal and Infant Probiotics Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Maternal and Infant Probiotics Market Scenario by Region
3.1 Global Maternal and Infant Probiotics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Maternal and Infant Probiotics Sales by Region: 2020-2031
3.2.1 Global Maternal and Infant Probiotics Sales by Region: 2020-2025
3.2.2 Global Maternal and Infant Probiotics Sales by Region: 2026-2031
3.3 Global Maternal and Infant Probiotics Revenue by Region: 2020-2031
3.3.1 Global Maternal and Infant Probiotics Revenue by Region: 2020-2025
3.3.2 Global Maternal and Infant Probiotics Revenue by Region: 2026-2031
3.4 North America Maternal and Infant Probiotics Market Facts & Figures by Country
3.4.1 North America Maternal and Infant Probiotics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Maternal and Infant Probiotics Sales by Country (2020-2031)
3.4.3 North America Maternal and Infant Probiotics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Maternal and Infant Probiotics Market Facts & Figures by Country
3.5.1 Europe Maternal and Infant Probiotics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Maternal and Infant Probiotics Sales by Country (2020-2031)
3.5.3 Europe Maternal and Infant Probiotics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Maternal and Infant Probiotics Market Facts & Figures by Region
3.6.1 Asia Pacific Maternal and Infant Probiotics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Maternal and Infant Probiotics Sales by Region (2020-2031)
3.6.3 Asia Pacific Maternal and Infant Probiotics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Maternal and Infant Probiotics Market Facts & Figures by Country
3.7.1 Latin America Maternal and Infant Probiotics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Maternal and Infant Probiotics Sales by Country (2020-2031)
3.7.3 Latin America Maternal and Infant Probiotics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Maternal and Infant Probiotics Market Facts & Figures by Country
3.8.1 Middle East and Africa Maternal and Infant Probiotics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Maternal and Infant Probiotics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Maternal and Infant Probiotics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Maternal and Infant Probiotics Sales by Type (2020-2031)
4.1.1 Global Maternal and Infant Probiotics Sales by Type (2020-2025)
4.1.2 Global Maternal and Infant Probiotics Sales by Type (2026-2031)
4.1.3 Global Maternal and Infant Probiotics Sales Market Share by Type (2020-2031)
4.2 Global Maternal and Infant Probiotics Revenue by Type (2020-2031)
4.2.1 Global Maternal and Infant Probiotics Revenue by Type (2020-2025)
4.2.2 Global Maternal and Infant Probiotics Revenue by Type (2026-2031)
4.2.3 Global Maternal and Infant Probiotics Revenue Market Share by Type (2020-2031)
4.3 Global Maternal and Infant Probiotics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Maternal and Infant Probiotics Sales by Application (2020-2031)
5.1.1 Global Maternal and Infant Probiotics Sales by Application (2020-2025)
5.1.2 Global Maternal and Infant Probiotics Sales by Application (2026-2031)
5.1.3 Global Maternal and Infant Probiotics Sales Market Share by Application (2020-2031)
5.2 Global Maternal and Infant Probiotics Revenue by Application (2020-2031)
5.2.1 Global Maternal and Infant Probiotics Revenue by Application (2020-2025)
5.2.2 Global Maternal and Infant Probiotics Revenue by Application (2026-2031)
5.2.3 Global Maternal and Infant Probiotics Revenue Market Share by Application (2020-2031)
5.3 Global Maternal and Infant Probiotics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Bayer Corporation
6.1.1 Bayer Corporation Company Information
6.1.2 Bayer Corporation Description and Business Overview
6.1.3 Bayer Corporation Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Bayer Corporation Maternal and Infant Probiotics Product Portfolio
6.1.5 Bayer Corporation Recent Developments/Updates
6.2 Nestle S.A
6.2.1 Nestle S.A Company Information
6.2.2 Nestle S.A Description and Business Overview
6.2.3 Nestle S.A Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nestle S.A Maternal and Infant Probiotics Product Portfolio
6.2.5 Nestle S.A Recent Developments/Updates
6.3 Mommy’s Bliss Inc
6.3.1 Mommy’s Bliss Inc Company Information
6.3.2 Mommy’s Bliss Inc Description and Business Overview
6.3.3 Mommy’s Bliss Inc Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mommy’s Bliss Inc Maternal and Infant Probiotics Product Portfolio
6.3.5 Mommy’s Bliss Inc Recent Developments/Updates
6.4 LoveBug Probiotics
6.4.1 LoveBug Probiotics Company Information
6.4.2 LoveBug Probiotics Description and Business Overview
6.4.3 LoveBug Probiotics Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LoveBug Probiotics Maternal and Infant Probiotics Product Portfolio
6.4.5 LoveBug Probiotics Recent Developments/Updates
6.5 BioGaia AB
6.5.1 BioGaia AB Company Information
6.5.2 BioGaia AB Description and Business Overview
6.5.3 BioGaia AB Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioGaia AB Maternal and Infant Probiotics Product Portfolio
6.5.5 BioGaia AB Recent Developments/Updates
6.6 MaryRuth Organics
6.6.1 MaryRuth Organics Company Information
6.6.2 MaryRuth Organics Description and Business Overview
6.6.3 MaryRuth Organics Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MaryRuth Organics Maternal and Infant Probiotics Product Portfolio
6.6.5 MaryRuth Organics Recent Developments/Updates
6.7 Infinant Health
6.7.1 Infinant Health Company Information
6.7.2 Infinant Health Description and Business Overview
6.7.3 Infinant Health Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Infinant Health Maternal and Infant Probiotics Product Portfolio
6.7.5 Infinant Health Recent Developments/Updates
6.8 Biomeology
6.8.1 Biomeology Company Information
6.8.2 Biomeology Description and Business Overview
6.8.3 Biomeology Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomeology Maternal and Infant Probiotics Product Portfolio
6.8.5 Biomeology Recent Developments/Updates
6.9 Nordic Naturals
6.9.1 Nordic Naturals Company Information
6.9.2 Nordic Naturals Description and Business Overview
6.9.3 Nordic Naturals Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nordic Naturals Maternal and Infant Probiotics Product Portfolio
6.9.5 Nordic Naturals Recent Developments/Updates
6.10 Culturelle
6.10.1 Culturelle Company Information
6.10.2 Culturelle Description and Business Overview
6.10.3 Culturelle Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Culturelle Maternal and Infant Probiotics Product Portfolio
6.10.5 Culturelle Recent Developments/Updates
6.11 Life-Space
6.11.1 Life-Space Company Information
6.11.2 Life-Space Description and Business Overview
6.11.3 Life-Space Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Life-Space Maternal and Infant Probiotics Product Portfolio
6.11.5 Life-Space Recent Developments/Updates
6.12 Witsbb
6.12.1 Witsbb Company Information
6.12.2 Witsbb Description and Business Overview
6.12.3 Witsbb Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Witsbb Maternal and Infant Probiotics Product Portfolio
6.12.5 Witsbb Recent Developments/Updates
6.13 Biostime
6.13.1 Biostime Company Information
6.13.2 Biostime Description and Business Overview
6.13.3 Biostime Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Biostime Maternal and Infant Probiotics Product Portfolio
6.13.5 Biostime Recent Developments/Updates
6.14 BY-health
6.14.1 BY-health Company Information
6.14.2 BY-health Description and Business Overview
6.14.3 BY-health Maternal and Infant Probiotics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 BY-health Maternal and Infant Probiotics Product Portfolio
6.14.5 BY-health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Maternal and Infant Probiotics Industry Chain Analysis
7.2 Maternal and Infant Probiotics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Maternal and Infant Probiotics Production Mode & Process Analysis
7.4 Maternal and Infant Probiotics Sales and Marketing
7.4.1 Maternal and Infant Probiotics Sales Channels
7.4.2 Maternal and Infant Probiotics Distributors
7.5 Maternal and Infant Probiotics Customer Analysis
8 Maternal and Infant Probiotics Market Dynamics
8.1 Maternal and Infant Probiotics Industry Trends
8.2 Maternal and Infant Probiotics Market Drivers
8.3 Maternal and Infant Probiotics Market Challenges
8.4 Maternal and Infant Probiotics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Maternal and Infant Probiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Maternal and Infant Probiotics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Maternal and Infant Probiotics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Maternal and Infant Probiotics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Maternal and Infant Probiotics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Maternal and Infant Probiotics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Maternal and Infant Probiotics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Maternal and Infant Probiotics Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Maternal and Infant Probiotics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Maternal and Infant Probiotics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Maternal and Infant Probiotics, Product Type & Application
 Table 12. Global Key Manufacturers of Maternal and Infant Probiotics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Maternal and Infant Probiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Maternal and Infant Probiotics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Maternal and Infant Probiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Maternal and Infant Probiotics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Maternal and Infant Probiotics Sales Market Share by Region (2020-2025)
 Table 19. Global Maternal and Infant Probiotics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Maternal and Infant Probiotics Sales Market Share by Region (2026-2031)
 Table 21. Global Maternal and Infant Probiotics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Maternal and Infant Probiotics Revenue Market Share by Region (2020-2025)
 Table 23. Global Maternal and Infant Probiotics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Maternal and Infant Probiotics Revenue Market Share by Region (2026-2031)
 Table 25. North America Maternal and Infant Probiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Maternal and Infant Probiotics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Maternal and Infant Probiotics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Maternal and Infant Probiotics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Maternal and Infant Probiotics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Maternal and Infant Probiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Maternal and Infant Probiotics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Maternal and Infant Probiotics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Maternal and Infant Probiotics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Maternal and Infant Probiotics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Maternal and Infant Probiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Maternal and Infant Probiotics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Maternal and Infant Probiotics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Maternal and Infant Probiotics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Maternal and Infant Probiotics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Maternal and Infant Probiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Maternal and Infant Probiotics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Maternal and Infant Probiotics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Maternal and Infant Probiotics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Maternal and Infant Probiotics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Maternal and Infant Probiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Maternal and Infant Probiotics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Maternal and Infant Probiotics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Maternal and Infant Probiotics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Maternal and Infant Probiotics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Maternal and Infant Probiotics Sales (K Units) by Type (2020-2025)
 Table 51. Global Maternal and Infant Probiotics Sales (K Units) by Type (2026-2031)
 Table 52. Global Maternal and Infant Probiotics Sales Market Share by Type (2020-2025)
 Table 53. Global Maternal and Infant Probiotics Sales Market Share by Type (2026-2031)
 Table 54. Global Maternal and Infant Probiotics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Maternal and Infant Probiotics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Maternal and Infant Probiotics Revenue Market Share by Type (2020-2025)
 Table 57. Global Maternal and Infant Probiotics Revenue Market Share by Type (2026-2031)
 Table 58. Global Maternal and Infant Probiotics Price (US$/L) by Type (2020-2025)
 Table 59. Global Maternal and Infant Probiotics Price (US$/L) by Type (2026-2031)
 Table 60. Global Maternal and Infant Probiotics Sales (K Units) by Application (2020-2025)
 Table 61. Global Maternal and Infant Probiotics Sales (K Units) by Application (2026-2031)
 Table 62. Global Maternal and Infant Probiotics Sales Market Share by Application (2020-2025)
 Table 63. Global Maternal and Infant Probiotics Sales Market Share by Application (2026-2031)
 Table 64. Global Maternal and Infant Probiotics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Maternal and Infant Probiotics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Maternal and Infant Probiotics Revenue Market Share by Application (2020-2025)
 Table 67. Global Maternal and Infant Probiotics Revenue Market Share by Application (2026-2031)
 Table 68. Global Maternal and Infant Probiotics Price (US$/L) by Application (2020-2025)
 Table 69. Global Maternal and Infant Probiotics Price (US$/L) by Application (2026-2031)
 Table 70. Bayer Corporation Company Information
 Table 71. Bayer Corporation Description and Business Overview
 Table 72. Bayer Corporation Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Bayer Corporation Maternal and Infant Probiotics Product
 Table 74. Bayer Corporation Recent Developments/Updates
 Table 75. Nestle S.A Company Information
 Table 76. Nestle S.A Description and Business Overview
 Table 77. Nestle S.A Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Nestle S.A Maternal and Infant Probiotics Product
 Table 79. Nestle S.A Recent Developments/Updates
 Table 80. Mommy’s Bliss Inc Company Information
 Table 81. Mommy’s Bliss Inc Description and Business Overview
 Table 82. Mommy’s Bliss Inc Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 83. Mommy’s Bliss Inc Maternal and Infant Probiotics Product
 Table 84. Mommy’s Bliss Inc Recent Developments/Updates
 Table 85. LoveBug Probiotics Company Information
 Table 86. LoveBug Probiotics Description and Business Overview
 Table 87. LoveBug Probiotics Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 88. LoveBug Probiotics Maternal and Infant Probiotics Product
 Table 89. LoveBug Probiotics Recent Developments/Updates
 Table 90. BioGaia AB Company Information
 Table 91. BioGaia AB Description and Business Overview
 Table 92. BioGaia AB Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 93. BioGaia AB Maternal and Infant Probiotics Product
 Table 94. BioGaia AB Recent Developments/Updates
 Table 95. MaryRuth Organics Company Information
 Table 96. MaryRuth Organics Description and Business Overview
 Table 97. MaryRuth Organics Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 98. MaryRuth Organics Maternal and Infant Probiotics Product
 Table 99. MaryRuth Organics Recent Developments/Updates
 Table 100. Infinant Health Company Information
 Table 101. Infinant Health Description and Business Overview
 Table 102. Infinant Health Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 103. Infinant Health Maternal and Infant Probiotics Product
 Table 104. Infinant Health Recent Developments/Updates
 Table 105. Biomeology Company Information
 Table 106. Biomeology Description and Business Overview
 Table 107. Biomeology Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 108. Biomeology Maternal and Infant Probiotics Product
 Table 109. Biomeology Recent Developments/Updates
 Table 110. Nordic Naturals Company Information
 Table 111. Nordic Naturals Description and Business Overview
 Table 112. Nordic Naturals Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 113. Nordic Naturals Maternal and Infant Probiotics Product
 Table 114. Nordic Naturals Recent Developments/Updates
 Table 115. Culturelle Company Information
 Table 116. Culturelle Description and Business Overview
 Table 117. Culturelle Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 118. Culturelle Maternal and Infant Probiotics Product
 Table 119. Culturelle Recent Developments/Updates
 Table 120. Life-Space Company Information
 Table 121. Life-Space Description and Business Overview
 Table 122. Life-Space Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 123. Life-Space Maternal and Infant Probiotics Product
 Table 124. Life-Space Recent Developments/Updates
 Table 125. Witsbb Company Information
 Table 126. Witsbb Description and Business Overview
 Table 127. Witsbb Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 128. Witsbb Maternal and Infant Probiotics Product
 Table 129. Witsbb Recent Developments/Updates
 Table 130. Biostime Company Information
 Table 131. Biostime Description and Business Overview
 Table 132. Biostime Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 133. Biostime Maternal and Infant Probiotics Product
 Table 134. Biostime Recent Developments/Updates
 Table 135. BY-health Company Information
 Table 136. BY-health Description and Business Overview
 Table 137. BY-health Maternal and Infant Probiotics Sales (K Units), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 138. BY-health Maternal and Infant Probiotics Product
 Table 139. BY-health Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Maternal and Infant Probiotics Distributors List
 Table 143. Maternal and Infant Probiotics Customers List
 Table 144. Maternal and Infant Probiotics Market Trends
 Table 145. Maternal and Infant Probiotics Market Drivers
 Table 146. Maternal and Infant Probiotics Market Challenges
 Table 147. Maternal and Infant Probiotics Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Maternal and Infant Probiotics
 Figure 2. Global Maternal and Infant Probiotics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Maternal and Infant Probiotics Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Liquid Product Picture
 Figure 6. Soft Candy Product Picture
 Figure 7. Global Maternal and Infant Probiotics Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Maternal and Infant Probiotics Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Supermarkets
 Figure 12. Others
 Figure 13. Global Maternal and Infant Probiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Maternal and Infant Probiotics Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Maternal and Infant Probiotics Sales (2020-2031) & (K Units)
 Figure 16. Global Maternal and Infant Probiotics Average Price (US$/L) & (2020-2031)
 Figure 17. Maternal and Infant Probiotics Report Years Considered
 Figure 18. Maternal and Infant Probiotics Sales Share by Manufacturers in 2024
 Figure 19. Global Maternal and Infant Probiotics Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Maternal and Infant Probiotics Players: Market Share by Revenue in Maternal and Infant Probiotics in 2024
 Figure 21. Maternal and Infant Probiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Maternal and Infant Probiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Maternal and Infant Probiotics Sales Market Share by Country (2020-2031)
 Figure 24. North America Maternal and Infant Probiotics Revenue Market Share by Country (2020-2031)
 Figure 25. United States Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Maternal and Infant Probiotics Sales Market Share by Country (2020-2031)
 Figure 28. Europe Maternal and Infant Probiotics Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Maternal and Infant Probiotics Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Maternal and Infant Probiotics Revenue Market Share by Region (2020-2031)
 Figure 36. China Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Maternal and Infant Probiotics Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Maternal and Infant Probiotics Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Maternal and Infant Probiotics Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Maternal and Infant Probiotics Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Maternal and Infant Probiotics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Maternal and Infant Probiotics by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Maternal and Infant Probiotics by Type (2020-2031)
 Figure 56. Global Maternal and Infant Probiotics Price (US$/L) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Maternal and Infant Probiotics by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Maternal and Infant Probiotics by Application (2020-2031)
 Figure 59. Global Maternal and Infant Probiotics Price (US$/L) by Application (2020-2031)
 Figure 60. Maternal and Infant Probiotics Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure